Taiwan FDA registration 0347d2da07d9cc6d5ee576cf4a129be5
Rightest CARE App
TW: 瑞特血糖守護寶
Taiwan·Risk Class 2·MD·Daqing Factory of Huaguang Biotechnology Co., Ltd·Registered Jul 06, 2018 – Jul 06, 2028ActiveRegistration details
- Analysis ID
- 0347d2da07d9cc6d5ee576cf4a129be5
- License Form
- Ministry of Health Medical Device Manufacturing No. 005985
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Daqing Factory of Huaguang Biotechnology Co., Ltd
Product details
- Intended Use
- This product can enter blood glucose value through Bluetooth transmission or manual keyboard, the data will be transmitted to the Rite comprehensive blood glucose management system account, family or professional users can view blood glucose records, or analyze and manage through the App, or optionally share the information with authorized medical institutions. This product is not intended for the treatment, diagnosis or screening of all types of diabetes.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jul 06, 2018
- Expiry Date
- Jul 06, 2028
About this record
Access comprehensive regulatory information for Rightest CARE App in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0347d2da07d9cc6d5ee576cf4a129be5 and manufactured by Daqing Factory of Huaguang Biotechnology Co., Ltd. The authorized representative in Taiwan is Daqing Factory of Huaguang Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices